Dapagliflozin mitigates oxidative stress, inflammatory, and histopathological markers of aging in mice
- PMID: 38813367
- PMCID: PMC11131629
- DOI: 10.25122/jml-2023-0343
Dapagliflozin mitigates oxidative stress, inflammatory, and histopathological markers of aging in mice
Abstract
Aging, a complex physiological process affecting all living things, is a major area of research, particularly focused on interventions to slow its progression. This study assessed the antiaging efficacy of dapagliflozin (DAPA) on various aging-related parameters in a mouse model artificially induced to age. Forty male Swiss albino mice were randomly divided into four groups of ten animals each. The control group (Group I) received normal saline. The aging model group (Group II) was administered D-galactose orally at 500mg/kg to induce aging. Following the aging induction, the positive control group received Vitamin C supplementation (Group III), while the DAPA group (Group IV) was treated with dapagliflozin. The inflammatory mediators (TNF-α and IL-1β) showed similar patterns of change. No statistically significant difference was observed between groups III and IV. Both groups had significantly lower values compared to GII, while it was significantly higher compared to GI. Glutathione peroxidase (GSH-Px) showed no statistically significant difference between groups GIII and GIV, but it was higher in GIII compared to GII and significantly lower in GIII compared to GI. The study demonstrated that dapagliflozin exerts a beneficial impact on many indicators of aging in mice. The intervention resulted in a reduction in hypertrophy in cardiomyocytes, an enhancement in skin vitality, a decrease in the presence of inflammatory mediators, and an improvement in the efficacy of antioxidants.
Keywords: AGEs, Advanced Glycation End Products; CVD, Cardiovascular Disease; Ca2+, Calcium; Col-I, Collagen I; Col-III, Collagen III; DAPA, Dapagliflozin; Dapagliflozin; GSH-Px, Glutathione Peroxidase; H&E, Hematoxylin and Eosin Stain; HPF, High Power Fields; IL-1β, Interleukin-1 Beta; IP, Intraperitoneally; MDA, Malondialdehyde; ROS, Reactive Oxygen Species; SD, Standard Deviation; SGLT2, Sodium-Glucose Cotransporter-2; SGLT2i, Sodium-Glucose Cotransporter 2 Inhibitors; TNF-α, Tumor Necrosis Factor-Alpha; aging; heart; inflammation; oxidative stress; skin.
© 2024 by the authors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Dapagliflozin inhibits ferroptosis to improve chronic heart failure by regulating Nrf2/HO-1/GPX4 signaling pathway.PLoS One. 2025 Jan 28;20(1):e0317295. doi: 10.1371/journal.pone.0317295. eCollection 2025. PLoS One. 2025. PMID: 39874368 Free PMC article.
-
Comparison of the cardioprotective effects of liraglutide, dapagliflozin and their combination in a rat model of diabetes induced by streptozotocin.Life Sci. 2025 Aug 15;375:123721. doi: 10.1016/j.lfs.2025.123721. Epub 2025 May 17. Life Sci. 2025. PMID: 40389022
-
Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation.Int Immunopharmacol. 2022 Mar;104:108503. doi: 10.1016/j.intimp.2021.108503. Epub 2022 Jan 5. Int Immunopharmacol. 2022. PMID: 34998036
-
Potential anti-inflammatory effect of dapagliflozin in HCHF diet- induced fatty liver degeneration through inhibition of TNF-α, IL-1β, and IL-18 in rat liver.Int Immunopharmacol. 2020 Sep;86:106730. doi: 10.1016/j.intimp.2020.106730. Epub 2020 Jun 26. Int Immunopharmacol. 2020. PMID: 32599319
-
A review regarding the article 'Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement'.Curr Probl Cardiol. 2024 Jun;49(6):102563. doi: 10.1016/j.cpcardiol.2024.102563. Epub 2024 Apr 8. Curr Probl Cardiol. 2024. PMID: 38599557 Review.
Cited by
-
Mitigative Effects of Topical Norfloxacin on an Imiquimod-Induced Murine Model of Psoriasis.ACS Pharmacol Transl Sci. 2024 Aug 2;7(9):2739-2754. doi: 10.1021/acsptsci.4c00152. eCollection 2024 Sep 13. ACS Pharmacol Transl Sci. 2024. PMID: 39296262 Free PMC article.
-
The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation.Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2695-2715. doi: 10.1007/s00210-024-03406-y. Epub 2024 Sep 10. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39254877
-
SGLT2 Inhibitors in Glomerulonephritis: Beyond Nephroprotection?J Clin Med. 2025 May 18;14(10):3533. doi: 10.3390/jcm14103533. J Clin Med. 2025. PMID: 40429528 Free PMC article. Review.
-
Azilsartan as a preventive agent against cyclophosphamide-induced testicular injury in male rats.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):979-990. doi: 10.1007/s00210-024-03339-6. Epub 2024 Aug 2. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39093466
-
Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy.Biomolecules. 2025 Feb 14;15(2):286. doi: 10.3390/biom15020286. Biomolecules. 2025. PMID: 40001588 Free PMC article.
References
-
- Kirkwood TB. Understanding the odd science of aging. Cell. 2005;120(4):437–47. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous